Počet záznamov: 1
Graves' disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis
SYS 0175543 LBL 00000naa--2200000-a-4500 005 20250607173700.1 008 211004s2021----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a Graves' disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis / $c Diana Borges Duarte ... [et al.] 300 $b ilustr., tab. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d020528 $a skleróza multiplex, progresívna chronická $x farmakoterapia $x komplikácie $2 mesh 650 12
$7 sllk_us_auth*d006980 $a hypertyreóza $2 mesh 650 22
$7 sllk_us_auth*d013963 $a hormóny štítnej žľazy $x analýza $2 mesh 650 12
$7 sllk_us_auth*d006111 $a Gravesova choroba $2 mesh 650 22
$7 sllk_us_auth*d057832 $a sledovanie pozorné $2 mesh 653 2-
$a skleróza multiplex primárne progresívna 653 2-
$a okrelizumab 653 2-
$a kazuistika 700 1-
$7 sllk_us_auth*0054475 $a Borges Duarte, Diana $4 aut 773 0-
$7 nnas $w sllk_us_cat*0174993 $t Endocrine regulations $x 1210-0668 $d Bratislava : Institute of Experimental Endocrinology, 2021 $g Vol. 55, no. 3 (2021), s. 169-173
Počet záznamov: 1